Editorial

March 31, 2025


Editorial for JUO 2025 Vol. 23 No. 1 - Highlights of This Issue’s Papers and the JUO Editors’ Pick
Cheol Kwak
J Urol Oncol. 2025;23(1):1-3.

Invited Review

March 31, 2025


Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
Gabriela M. Diaz, Peter S. Palencia, Michael S. Leapman
J Urol Oncol. 2025;23(1):4-13.

Original Article

March 31, 2025


The Clinical Impact of Depression and Anxiety on Complications After Prostate Cancer Treatment: A Retrospective Cohort Study
Elliott J. Druten, Will P. Hoover, Jacob Bardell, et al.
J Urol Oncol. 2025;23(1):14-19.

Original Article

March 31, 2025


A Urologist’s Perspective: Initial Experiences With SpaceOAR Hydrogel Insertion for Prostate Cancer Patients
Hyunho Han, Ik Jae Lee, Woong Sub Koom, et al.
J Urol Oncol. 2025;23(1):20-29.

Original Article

March 31, 2025


Prognostic Impact of Seminal Vesicle Mucosal Invasion in pT3b Prostate Cancer Following Radical Prostatectomy
Hyun Jung Lee, Won Hoon Song, Seung Soo Lee, et al.
J Urol Oncol. 2025;23(1):30-37.

Invited Review

March 31, 2025


Selection of Optimal Neoadjuvant Therapy Before Cytoreductive Nephrectomy and Its Biomarker in Renal Cell Carcinoma
Renpei Kato
J Urol Oncol. 2025;23(1):38-46.

Original Article

March 31, 2025


Predicting Oncological and Functional Outcomes by Nephrectomy Type for T1 Renal Tumors Using Machine Learning Models
Dongrul Shin, Maisy Song, Jungyo Suh, et al.
J Urol Oncol. 2025;23(1):47-53.

Original Article

March 31, 2025


Prognostic Implications of Serum Carbonic Anhydrase IX in Clear Cell Renal Cell Carcinoma
Mónica Sanz del Pozo, Cristina Plaza Alonso, Álvaro Linacero Gracia, et al.
J Urol Oncol. 2025;23(1):54-62.

Invited Review

March 31, 2025


A Review of Emerging Neoadjuvant Intravesical Strategies to Enhance Systemic Immune Checkpoint Blockade in Patients With Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Through the Induction of Immunogenic Cell Death and Activation of Tertiary Lymphoid Structure formation
Hye Won Lee, Hyun Hwan Sung
J Urol Oncol. 2025;23(1):63-78.

Original Article

March 31, 2025


Impact of Extended Lymph Node Dissection on Survival Outcomes in Patients With Bladder Cancer and Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study
Jiwoong Yu, Wook Nam, Kyung Hwan Kim, et al.
J Urol Oncol. 2025;23(1):79-87.

Original Article

March 31, 2025


Gender and Menopause Impact on Recurrence and Cancer-Specific Mortality in Bladder Cancer After Radical Cystectomy: A Retrospective Cohort Study
Jee Soo Park, Won Sik Jang, Jieun Heo, et al.
J Urol Oncol. 2025;23(1):88-93.
Complex Epidemiology of Prostate Cancer in Asian Countries  (7,511 times)
Kagenori Ito, Takahiro Kimura
J Urol Oncol. 2023;21(1):5-13.

Review Article

Mar 31, 2023

Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023  (5,561 times)
Jiwoong Yu, Hyun Hwan Sung
J Urol Oncol. 2023;21(3):228-240.

Invited Review

Nov 30, 2023

Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type  (5,091 times)
Chan Woo Wee, Jaeho Cho
J Urol Oncol. 2023;21(3):217-227.

Invited Review

Nov 30, 2023

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Current Update on Prostate Cancer Immunotherapy  (4,822 times)
Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim
J Urol Oncol. 2023;21(1):14-22.

Review Article

Mar 31, 2023

Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up  (4,142 times)
Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al.
J Urol Oncol. 2023;21(1):70-78.

Original Article

Mar 31, 2023

The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects  (4,113 times)
Hyerim Ha, Joo Han Lim
J Urol Oncol. 2023;21(3):208-216.

Invited Review

Nov 30, 2023

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades  (4,052 times)
Sang Heon Han, Hyeong Dong Yuk
J Urol Oncol. 2023;21(1):32-44.

Original Article

Mar 31, 2023

The Landscape of Epidemiology in Urologic Cancers
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients  (3,888 times)
Stefani Frost, Parisa Ziarati, Ryan Moen, et al.
J Urol Oncol. 2024;22(1):78-94.

Systemic Review and Meta-analysis

Mar 31, 2024

Bladder Cancer
Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer  (3,844 times)
Hyunho Han, Minyong Kang, Seok-Soo Byun, et al.
J Urol Oncol. 2023;21(2):128-139.

Invited Review

Jul 31, 2023

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies  (3,763 times)
Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, et al.
J Urol Oncol. 2023;21(1):23-31.

Review Article

Mar 31, 2023

Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis  (3,674 times)
Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, et al.
J Urol Oncol. 2023;21(2):165-173.

Original Article

Jul 31, 2023

Trimodality Therapy and Immuno-Oncology for Bladder Cancer
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening  (3,626 times)
Jung Sik Huh, Kyung Kgi Park
J Urol Oncol. 2023;21(2):121-127.

Original Article

Jul 31, 2023

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials  (3,614 times)
Sang Hun Song, Jong Jin Oh
J Urol Oncol. 2023;21(2):154-164.

Invited Review

Jul 31, 2023

Trimodality Therapy and Immuno-Oncology for Bladder Cancer
Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma  (3,555 times)
Sung Han Kim, Ilma S. Savul, Seth P. Lerner
J Urol Oncol. 2024;22(1):68-77.

Invited Review

Mar 31, 2024

Bladder Cancer
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review  (3,495 times)
Chang Wook Jeong
J Urol Oncol. 2024;22(1):4-10.

Invited Review

Mar 31, 2024

Prostate Cancer
The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance  (3,491 times)
Chang Wook Jeong
J Urol Oncol. 2023;21(2):97-105.

Invited Review

Jul 31, 2023

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy  (3,430 times)
Jin Hyuck Kim, Young Hwii Ko, Jong Wook Kim, et al.
J Urol Oncol. 2023;21(1):79-87.

Original Article

Mar 31, 2023

Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use  (3,322 times)
Byung Kwan Park
J Urol Oncol. 2023;21(2):106-111.

Invited Review

Jul 31, 2023

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database  (3,196 times)
Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, et al.
J Urol Oncol. 2023;21(1):45-52.

Original Article

Mar 31, 2023

Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma  (3,097 times)
Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al.
J Urol Oncol. 2023;21(3):183-199.

Invited Review

Nov 30, 2023

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis  (3,055 times)
Jin Noh, Sang Hun Song, Gyoohwan Jung, et al.
J Urol Oncol. 2023;21(3):200-207.

Topic Article

Nov 30, 2023

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians  (3,045 times)
Bokyung Ahn, Jinahn Jeong, Yong Il Lee, et al.
J Urol Oncol. 2024;22(2):115-127.

Invited Review

Jul 31, 2024

Renal Cell Carcinoma
Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey  (3,032 times)
Joongwon Choi, Cheryn Song, Jungyo Suh, et al.
J Urol Oncol. 2023;21(1):59-69.

Original Article

Mar 31, 2023

Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery?  (3,002 times)
Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, et al.
J Urol Oncol. 2023;21(2):140-147.

Invited Review

Jul 31, 2023

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma  (3,002 times)
Dongsu Kim, Bumjin Lim, Jungyo Suh, et al.
J Urol Oncol. 2023;21(2):148-153.

Original Article

Jul 31, 2023

Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy  (2,985 times)
Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al.
J Urol Oncol. 2023;21(3):249-256.Correction in: 2024;22(2):183

Original Article

Nov 30, 2023

Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review  (2,983 times)
Minseok Suh, Gi Jeong Cheon
J Urol Oncol. 2024;22(1):11-20.

Invited Review

Mar 31, 2024

Prostate Cancer
Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer  (2,981 times)
Jaeyoung Cho, Jungyo Suh, Dalsan You, et al.
J Urol Oncol. 2023;21(3):257-263.

Topic Article

Nov 30, 2023

Clinical Predictors of ARTA Response in Metastatic Prostate Cancer
Summarizing the Intentions and Outcomes of Journal of Urologic Oncology 2024 Issue 2  (2,831 times)
Cheol Kwak
J Urol Oncol. 2024;22(2):97-99.

Editorial

Jul 31, 2024

Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion  (2,815 times)
Vanessa M. Hayes, Sean M. Patrick, Joyce Shirinde, et al.
J Urol Oncol. 2024;22(2):144-149.

Invited Review

Jul 31, 2024

Prostate Cancer

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.

Developed in M2PI